Abstract
Eli Lilly is inviting early-stage biotechs to make use of drug discovery models that the pharma is providing via a new AI platform.
Key Data
-
Publication Date09 September 2025
-
Primary AuthorJames Waldron
-
SourceFierce Biotech
-
LanguageEnglish
Click below to visit original source: